The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial evaluating MRG-106, a synthetic inhibitor of microRNA-155, in patients with cutaneous t-cell lymphoma (CTCL).
 
Francine M. Foss
Honoraria - miRagen; Seagen
Consulting or Advisory Role - Therakos
Speakers' Bureau - Celgene; Seagen
 
Christiane Querfeld
Consulting or Advisory Role - Actelion; Celgene; MiRagen
 
Pierluigi Porcu
Consulting or Advisory Role - Celgene; Innate Pharma; Millennium; miRagen
 
Youn H. Kim
Consulting or Advisory Role - Actelion; Eisai; Forty Seven; Kyowa Hakko Kirin; Medivir; Millennium; miRagen; Portola Pharmaceuticals; Seagen
Research Funding - Eisai; Forty Seven; Infinity Pharmaceuticals; Innate Pharma; Kyowa Hakko Kirin; Merck; Millennium; miRagen; Neumedicines; Seagen; Soligenix; TetraLogic Pharmaceuticals
 
Theresa Pacheco
No Relationships to Disclose
 
Ahmad Sami Halwani
Research Funding - Abbvie; Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Genentech; Immune Design; Kyowa Hakko Kirin; miRagen; Pharmacyclics; Roche/Genentech; Seagen; Takeda
Travel, Accommodations, Expenses - Abbvie; Pharmacyclics; Seagen
 
Jennifer DeSimone
Consulting or Advisory Role - Actelion
Speakers' Bureau - Actelion
Research Funding - DUSA Pharmaceuticals, Inc.
Travel, Accommodations, Expenses - Actelion
 
Basem M. William
Honoraria - miRagen
 
Anita G Seto
Employment - miRagen
Stock and Other Ownership Interests - miRagen
Research Funding - miRagen
Patents, Royalties, Other Intellectual Property - miRagen
 
Judy Ruckman
Employment - miRagen
Stock and Other Ownership Interests - miRagen
 
Michele L Landry
Consulting or Advisory Role - accera; miRagen
 
Aimee L Jackson
Employment - miRagen
Stock and Other Ownership Interests - miRagen
Patents, Royalties, Other Intellectual Property - miRagen
 
Linda A Pestano
Employment - Biodesix (I); miRagen
Stock and Other Ownership Interests - Biodesix (I); Cascadian Therapeutics; miRagen; Sanofi
Research Funding - miRagen
Patents, Royalties, Other Intellectual Property - Biodesix (Inst); Cascadian Therapeutics; ProIX; Seagen; Ventana Medical Systems
 
Brent A Dickinson
Employment - miRagen
Stock and Other Ownership Interests - miRagen
 
Mark Sanseverino
Employment - miRagen
Stock and Other Ownership Interests - miRagen
 
David M Rodman
Employment - miRagen; Nivalis Therapeutics
Leadership - miRagen; Nivalis Therapeutics
Stock and Other Ownership Interests - miRagen; Nivalis Therapeutics
Consulting or Advisory Role - miRagen
 
Paul Rubin
Employment - miRagen; miRagen; Xoma; Xoma
Leadership - miRagen
Stock and Other Ownership Interests - miRagen; Xoma
 
Gilad Shalag Gordon
Leadership - TEQ Analytic Laboratories
Stock and Other Ownership Interests - Takeda; Takeda; TEQ Analytic Laboratories; TEQ Analytic Laboratories
Consulting or Advisory Role - Axion Biosystems; Axion Biosystems; Axion Biosystems; Axion Biosystems; Bayer; Bayer; Bayer; Bayer; Clinipace; Clinipace; Clinipace; Clinipace; Clinipace; Clinipace; Clinipace; Fluidigm; Fluidigm; Fluidigm; Fluidigm; Globavir; Globavir; Globavir; Globavir; Globavir; Globavir; glpi; glpi; glpi; glpi; HERON; HERON; HERON; HERON; HERON; HERON; HERON; HERON; igm; igm; igm; igm; miRagen; miRagen; miRagen; miRagen; Pre-Cell; Pre-Cell; Pre-Cell; Pre-Cell; Pre-Cell; Pre-Cell; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
William S. Marshall
Employment - miRagen
Leadership - amidebio; BIOPtix; Flourofinder; miRagen
Stock and Other Ownership Interests - amidebio; BIOPtix; flourofinder; miRagen
Consulting or Advisory Role - amidebio; Atlas Ventures
Patents, Royalties, Other Intellectual Property - miRagen